Tavalisse
Active Ingredient(s): FostamatinibFDA Approved: * April 17, 2018
Pharm Company: * RIGEL PHARMS INC
Category: Immune System
Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a tyrosine kinase inhibitor medication for the treatment of chronic immune thrombocytopenia (ITP).[1][2] The drug is administered by mouth.[1][2] Fostamatinib blocks the activity of the enzyme spleen tyrosine kinase (SYK).[2] This enzyme is involved in stimulating parts of the immune system.[2] By blocking SYK's activity, fostamati... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Popular Topics
Tavalisse for low platelet count / chronic immune thrombocytopenia
A new drug by the name of Tavalisse (fostamatinib disodium hexahydrate) is reportedly being investigated for use in trea...